Applied Genetic Technologies (AGTC) Tops Q3 EPS by 5c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.50), $0.05 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 , versus $30 thousand reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13